Slide Resources

 

Here, you can search through all the slide resources available on this website: slide-sets from Meeting ResourcesESMO E-Learning modules; and Educational Slides.

 




Format available

https://oncologypro.esmo.org/Meeting-Resour...-and-prognostic-marker-in-gastric-cancer-24O

BackgroundDespite many advances in the diagnosis and treatment of gastric cancer (GC), the prognosis of patients with GC remains poor. Circular RNAs (circRNAs), a new star of the non-coding RNA network,...

Date: 17 Nov 2017
Section: Meeting Resources
Topics: Basic Science, Gastric Cancer, Translational Research

https://oncologypro.esmo.org/Meeting-Resour...gement-Conclusions-and-clinical-perspectives

Date: 17 Nov 2017
Section: Meeting Resources
Topics: Biomarkers, Central Nervous System Malignancies

https://oncologypro.esmo.org/Meeting-Resour...perative-setting-of-oesophago-gastric-cancer

Date: 17 Nov 2017
Section: Meeting Resources
Topics: Oesophageal Cancer, Gastric Cancer, Gastrointestinal Cancers, Personalised Medicine

https://oncologypro.esmo.org/Meeting-Resour...in-squamous-cell-carcinoma-of-the-oesophagus

Date: 17 Nov 2017
Section: Meeting Resources
Topics: Anti-Cancer Agents & Biologic Therapy, Oesophageal Cancer, Gastrointestinal Cancers, Surgery and/or Radiotherapy of Cancer

https://oncologypro.esmo.org/Meeting-Resour...nancy-and-management-challenges-Introduction

Date: 17 Nov 2017
Section: Meeting Resources
Topics: Cancer in Pregnancy, Cancer in Special Situations, Gynaecologic Malignancies

https://oncologypro.esmo.org/Meeting-Resour...ncy-Interim-analysis-on-more-than-1000-cases

Date: 17 Nov 2017
Section: Meeting Resources
Topic: Cancer in Pregnancy

https://oncologypro.esmo.org/Meeting-Resour...lenges-Conclusions-and-clinical-perspectives

Date: 17 Nov 2017
Section: Meeting Resources
Topics: Cancer in Pregnancy, Cancer in Special Situations, Gynaecologic Malignancies

https://oncologypro.esmo.org/Meeting-Resour...tion-ddPCR-in-oesophagogastric-OG-cancer-23O

BackgroundThe iMYC trial is a biomarker-driven study in advanced OG cancer that prospectively screens patients for MYC amplification to assess the feasibility of ibrutinib therapy.

Date: 17 Nov 2017
Section: Meeting Resources
Topics: Oesophageal Cancer, Gastrointestinal Cancers, Translational Research

https://oncologypro.esmo.org/Meeting-Resources/ESMO-Asia-2017-Congress/MGMT

Date: 17 Nov 2017
Section: Meeting Resources
Topics: Biomarkers, Central Nervous System Malignancies

https://oncologypro.esmo.org/Meeting-Resources/ESMO-Asia-2017-Congress/IDH-and-1p19q

Date: 17 Nov 2017
Section: Meeting Resources
Topics: Biomarkers, Central Nervous System Malignancies